Skip to content

A randomized controlled study of transcervical and transthoracic minimally invasive esophageal cancer resection

A randomized controlled study of transcervical and transthoracic minimally invasive esophageal cancer resection

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055312
Enrollment
Unknown
Registered
2022-01-06
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Transcervical Group:Cervical-Abdominal Esophagectomy
Transthoracic Group:Thoraco-Abdominal-Cervical Esophagectomy

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years, physical condition score ECOG 0-1; 2. Pathological diagnosis of esophageal cancer by gastroscopic biopsy, and the pathological type is squamous cell carcinoma or adenocarcinoma; 3. Endoscopic ultrasonography (EUS) and enhanced chest CT showed no obvious external invasion of the tumor, no obvious enlargement of mediastinal lymph nodes, and no distant organ metastasis, that is, esophageal cancer patients with preoperative clinical stage I (T1N0M0), IIa (T2N0M0, T3N0M0), and IIb (T1-2N1M0) stages (including patients after neoadjuvant therapy); 4. The subject has no major organ dysfunction; 5. Be able to understand the situation of this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of other malignant tumors; 2. Those who have serious complications and cannot operate; 3. Those who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Complication;

Secondary

MeasureTime frame
Survival period;Quality of life;

Countries

China

Contacts

Public ContactShen Yaxing

Zhongshan Hospital, Fudan University

shen.yaxing@zs-hospital.sh.cn+86 13661983366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026